A Sporadic Case of Charcot-Marie-Tooth Disease Type 2 with Left Vocal Fold Palsy due to Mitofusin 2 Mutation

被引:1
|
作者
Kanemaru, Kazuki [1 ]
Ogawa, Go [1 ]
Mochizuki, Hitoshi [1 ]
Nakazato, Masamitsu [1 ]
Shiomi, Kazutake [1 ]
机构
[1] Univ Miyazaki, Fac Med, Dept Internal Med, Div Neurol Respirol Endocrinol & Metab, Miyazaki, Japan
关键词
Charcot-Marie-Tooth disease type 2; hereditary motor and sensory neuropathy; mitofusin; 2; vocal fold palsy; optic atrophy; respiratory insufficiency; MFN2; MUTATIONS; CORD PARESIS; NEUROPATHY; PHENOTYPE; ONSET;
D O I
10.2169/internalmedicine.2318-18
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 33-year-old Japanese woman was referred for hoarseness. She had been diagnosed with Charcot-Marie-Tooth disease at age 3 and bilateral optic atrophy at age 15. Laryngoscopy revealed left vocal fold palsy. These findings suggested Charcot-Marie-Tooth disease type 2; the diagnosis was confirmed by a mitofusin 2 mutation analysis. Her symptoms remained stable for almost 10 years. Although vocal fold palsy and optic atrophy have been previously reported in patients with mitofusin 2 mutations, detailed clinical information and clinical course have never been documented. These data might contribute to the elucidation of the pathological conditions associated with mitofusin 2 mutations.
引用
收藏
页码:2091 / 2093
页数:3
相关论文
共 50 条
  • [41] Anticipation in Charcot-Marie-Tooth disease type 2 (CMT2)
    Vinci, P
    Oliveira, GR
    Antenor, JA
    Thomas, FP
    NEUROLOGY, 2001, 56 (08) : A324 - A325
  • [42] A Novel SPG11 mutation causing Charcot-Marie-Tooth Disease Type 2
    Sanghani, Nirav
    Maybodi, Leila
    Souayah, Nizar
    NEUROLOGY, 2020, 94 (15)
  • [43] Phenotypical and genotypical heterogeneity of Charcot-Marie-Tooth disease type 2A associated with the mitofusin 2 gene (MFN2)
    Angiari, C
    Cavallaro, T
    Ferrarini, M
    Taioli, F
    Cabrini, I
    Ferrari, S
    Fabrizi, GM
    Rizzuto, N
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2006, 11 (02) : 179 - 179
  • [45] Charcot-Marie-Tooth disease type 2 with restless legs syndrome
    Gemignani, F
    Marbini, A
    Di Giovanni, G
    Salih, S
    Terzano, MG
    NEUROLOGY, 1999, 52 (05) : 1064 - 1066
  • [46] Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations
    Amiott, Elizabeth A.
    Lott, Paul
    Soto, Jamie
    Kang, Peter B.
    McCaffery, J. Michael
    DiMauro, Salvatore
    Abel, E. Dale
    Flanigan, Kevin M.
    Lawson, Victoria H.
    Shaw, Janet M.
    EXPERIMENTAL NEUROLOGY, 2008, 211 (01) : 115 - 127
  • [47] Charcot-Marie-Tooth disease associated with Type 2 diabetes mellitus
    Çelik, M
    Forta, H
    Parman, Y
    Bissar-Tadmouri, N
    Demirkirkan, K
    Battaloglu, E
    DIABETIC MEDICINE, 2001, 18 (08) : 685 - 686
  • [48] CHARCOT-MARIE-TOOTH 2W. A NEW MUTATION?
    de Freitas, M.
    Dias, J.
    Vidal, C.
    Szklarz, D.
    Nascimento, O.
    Kok, F.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 268 - 268
  • [49] Co-occurrence of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease type 2A in a patient with a novel mutation in the mitofusin-2 gene
    Marchesi, Chiara
    Ciano, Claudia
    Salsano, Ettore
    Nanetti, Lorenzo
    Milani, Micaela
    Gellera, Cinzia
    Taroni, Franco
    Fabrizi, Gian Maria
    Uncini, Antonino
    Pareyson, Davide
    NEUROMUSCULAR DISORDERS, 2011, 21 (02) : 129 - 131
  • [50] Charcot-Marie-Tooth neuropathy type 2A:: novel mutations in the mitofusin 2 gene (MFN2)
    Engelfried, Kathrin
    Vorgerd, Matthias
    Hagedorn, Michaela
    Haas, Gerhard
    Gilles, Juergen
    Epplen, Joerg T.
    Meins, Moritz
    BMC MEDICAL GENETICS, 2006, 7